Importance of sulfhydryl groups for the uncoupling activity of non-steroidal acidic anti-inflammatory drugs and valinomycin in oxidative phosphorylation.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D003545:Cysteine / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D008566:Membranes / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D009840:Oligomycins / Q000494:pharmacology; D009941:Organomercury Compounds / Q000494:pharmacology; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D011188:Potassium / Q000378:metabolism; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013997:Time Factors; D014475:Uncoupling Agents / Q000494:pharmacology*; D014634:Valinomycin / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D004140:Dinitrophenols; D009840:Oligomycins; D009941:Organomercury Compounds; D011422:Propionates; D013438:Sulfhydryl Compounds; D014475:Uncoupling Agents; D014634:Valinomycin; D005439:Flufenamic Acid; D000244:Adenosine Diphosphate; D003545:Cysteine; D011188:Potassium; D007213:Indomethacin